Trial Profile
A pharmacokinetic study of telavancin in healthy male volunteers: A microdialysis study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Oct 2016
Price :
$35
*
At a glance
- Drugs Telavancin (Primary)
- Indications Gram-positive infections; Nosocomial pneumonia; Skin and soft tissue infections
- Focus Pharmacokinetics
- 27 Oct 2015 New trial record
- 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy